Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PMS-LAMOTRIGINE PHARMASCIENCE INC Actual shortage 25MG Updated Report 2022-12-06 175793
MAGNESIUM SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 500MG Updated Report 2022-12-06 159333
ELOCTATE SANOFI-AVENTIS CANADA INC Resolved 3000UNIT Updated Report 2022-12-06 171705
OMNARIS COVIS PHARMA GMBH Actual shortage 50MCG Updated Report 2022-12-06 175522
DEXAMETHASONE OMEGA UNIDOSE OMEGA LABORATORIES LIMITED Actual shortage 10MG Updated Report 2022-12-06 176292
NALOXONE INJECTABLE HIKMA CANADA LIMITED Actual shortage 0.4MG Updated Report 2022-12-06 177165
OLMETEC PLUS ORGANON CANADA INC. Actual shortage 25MG 40MG Updated Report 2022-12-05 170960
!!T3 PRO-AMOX-250 PRO DOC LIMITEE Actual shortage 250MG Updated Report 2022-12-05 175130
!!T3 PRO-AMOX-250 PRO DOC LIMITEE Actual shortage 250MG Updated Report 2022-12-05 175133
ADLYXINE SANOFI-AVENTIS CANADA INC Resolved 20MCG Updated Report 2022-12-05 173834
APO-ARIPIPRAZOLE APOTEX INC Actual shortage 5MG Updated Report 2022-12-05 177123
SUPRAX ODAN LABORATORIES LTD Actual shortage 100MG New Report 2022-12-05 177149
APO-ATENOL TAB 100MG APOTEX INC Resolved 100MG Updated Report 2022-12-05 175299
PMS-FAMPRIDINE PHARMASCIENCE INC Actual shortage 10MG Updated Report 2022-12-05 169462
PMS-BENZYDAMINE PHARMASCIENCE INC Resolved 0.15% Updated Report 2022-12-05 174490
DEFEROXAMINE MESYLATE FOR INJECTION PFIZER CANADA ULC Avoided shortage 2G Updated Report 2022-12-05 172596
ZARONTIN SEARCHLIGHT PHARMA INC Actual shortage 250MG Updated Report 2022-12-05 172389
ULTRA-TECHNEKOW V4 CURIUM CANADA INC Resolved 19CI Updated Report 2022-12-05 173407
PMS-TRANDOLAPRIL PHARMASCIENCE INC Avoided shortage 4MG Updated Report 2022-12-05 175796
APO-AMOXI CLAV APOTEX INC Actual shortage 125MG 250MG New Report 2022-12-05 177132

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
AMERGE GLAXOSMITHKLINE INC Discontinued 2.5MG Updated Report 2022-12-02 148430
XELODA CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 150MG Updated Report 2022-12-01 176355
XELODA CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 500MG Updated Report 2022-12-01 176359
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165397
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165462